18 Life Science Award Categories

Seed-Stage
Finance Raise of the Year

• Must be a fundraise by a private company
• Must be a company with European headquarters

FULL CRITERIA

Series A
Finance Raise of the Year

• Must be a fundraise by a private company
• Must be a company with European headquarters

FULL CRITERIA

Series B
Finance Raise of the Year

• Must be a fundraise by a private company
• Must be a company with European headquarters

FULL CRITERIA

Series C (& beyond)
Finance Raise of the Year

• Must be a fundraise by a private company
• Must be a company with European headquarters

FULL CRITERIA

IPO
of the Year

• Must be a public company
• Must be a company with a European headquarters
• Must be an IPO (primary, up-listing or dual-listing) NOT a secondary placement or follow-on

FULL CRITERIA

Hosted by:

Post-IPO Equity
Raise of the Year

• Must be a public company
• Must be a company with a European headquarters
• Raise must be a secondary placement, follow-on or PIPE, NOT an IPO, up-listing or dual-listing

FULL CRITERIA

Venture Capital
Firm of the Year

• Open to venture capital firms only
• Firm must have more than 20% portfolio holdings in healthcare and/or life sciences companies
• Firms must have headquarters in Europe

FULL CRITERIA

Deal of the Year
(<€500m)

• Deal size must be less than €500m
• The lead company must be a European Life Science company
• Open to private or public companies WITH peers, pharma, commercial leaders or big tech
• Deal can be either a licensing deal, single asset acquisition or collaborative agreement involving a particular drug, project or group of drugs/projects
• A license, partnership or alliance between companies NOT M&A

FULL CRITERIA

Deal of the Year
(>€500m)

• Deal size must be equal to or greater than €500m
• The lead company must be a European Life Science company
• Open to private or public companies WITH pharma, commercial leaders or big tech
• Deal can be either a licensing deal, single asset acquisition or collaborative agreement involving a particular drug, project or group of drugs/projects
• A license, partnership or alliance between companies NOT M&A

FULL CRITERIA

M&A
Deal of the Year

• The lead company must be a European Life Science company
• Open to private, public companies, pharma, commercial leaders or big tech
• Deal must be an M&A deal NOT a license, partnership or alliance

FULL CRITERIA

Pharma BD
Team of the Year

• Open to all pharma companies and large cap large cap biotech companies with a market capitalisation that is €1bn or above.
• Open to all business development teams or cross-company teams on a specific deal/project

FULL CRITERIA

Biotech
Company of the Year

• Open to all Biotech therapeutic companies with European Headquarters
• Open to all biotech companies companies with a market capitalisation that is €10bn or less

FULL CRITERIA

Medtech
Company of the Year

• Open to all Medtech/Medical Device/Diagnostics companies with European Headquarters
• Open to all Medtech/Medical Device/Diagnostics companies companies with a market capitalisation that is €10bn or less

FULL CRITERIA

Healthtech
Company of the Year

• Open to all Healthtech companies with European Headquarters
• Open to all Healthtech companies with a market capitalisation that is €10bn or less

FULL CRITERIA

Private Company
CEO of the Year

• Open to CEOs of privately owned life science companies
• Must be a company registered with European headquarters
  
  

FULL CRITERIA

Hosted by:

Public Company
CEO of the Year

• Open to CEOs of publicly-listed life science companies
• Must be a company registered with European headquarters

FULL CRITERIA

Black-Led Business
Leader of the Year

• Must be a Founder or C-suite level member of a private company
• Must be a company registered with European headquarters

FULL CRITERIA

Women-Led Business
Leader of the Year

• Must be a Founder or C-suite level member of a private company
• Must be a company registered with European headquarters

FULL CRITERIA